Expert Opinion on Pharmacotherapy
Overview
Expert Opinion on Pharmacotherapy is a reputable peer-reviewed journal that provides insightful analysis and expert opinions on various aspects of pharmacotherapy. It covers a wide range of topics including drug development, clinical trials, therapeutic strategies, and emerging trends in the field. With contributions from renowned experts, this journal serves as a valuable resource for healthcare professionals, researchers, and policymakers seeking evidence-based guidance in the field of pharmacotherapy.
Details
Details
Abbr.
Expert Opin Pharmacother
Publisher
Informa Healthcare
Start
1999
End
Continuing
Frequency
Eighteen no. a year, 2006-
p-ISSN
1465-6566
e-ISSN
1744-7666
Country
United Kingdom
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 3490
93
SJR / Ranks: 6476
687
CiteScore / Ranks: 3723
6.10
JIF / Ranks: 3189
3.2
Recent Articles
1.
Jain A, Cortes J
Expert Opin Pharmacother
. 2025 Mar;
PMID: 40087828
Introduction: Management of chronic phase chronic myeloid leukemia (CML-CP) was revolutionized with the development of tyrosine kinase inhibitors (TKIs). Imatinib (first generation), dasatinib, nilotinib and bosutinib (second generation) and ponatinib...
2.
Rendell M
Expert Opin Pharmacother
. 2025 Mar;
PMID: 40082213
Introduction: In the 100 years since isolation and administration of animal insulin to sustain life in Type 1 diabetes, there has been increasing progress in the administration of exogenous insulin...
3.
Ila V, Pozzi E, Gamage M, Ramasamy R
Expert Opin Pharmacother
. 2025 Mar;
:1-7.
PMID: 40069591
Introduction: Erectile dysfunction (ED) pathophysiology involves complex interactions between vasculogenic, hormonal, and neurological mechanisms, with endothelial dysfunction and oxidative stress playing crucial roles. There is growing interest in intravenous (IV)...
4.
Rendell M
Expert Opin Pharmacother
. 2025 Mar;
PMID: 40056035
Introduction: The last 100 years has seen type 1 diabetes, a previously fatal disease, transformed by the administration of exogenous insulin. Areas Covered: a standard literature search using the Google...
5.
Gibson C, Desai U, Wesling M
Expert Opin Pharmacother
. 2025 Mar;
:1-12.
PMID: 40035315
Introduction: Antithrombotic therapy is the cornerstone of stroke prevention, but standard of care therapies are underutilized and use is limited by bleeding rates, drug interactions, and renal elimination. Factor XI/XIa...
6.
Ettienne E, Grant-Kels J, Striano P, Russo E, Neubauer D, Rose K
Expert Opin Pharmacother
. 2025 Mar;
:1-9.
PMID: 40035212
Introduction: Melanoma is malignancy where, in recent years, drug treatment has massively improved prognosis and quality of life. Based on genetic analysis, we differentiate today melanomas caused by cumulative solar...
7.
Carter S, Biswas A, Watson H, Ip H, Fee E, Seah K, et al.
Expert Opin Pharmacother
. 2025 Mar;
PMID: 40033629
Introduction: A single course of antenatal steroid (ANS) therapy is standard of care for women at risk of preterm birth, reducing the risk of neonatal respiratory distress syndrome, neonatal morbidity...
8.
Stormann S, Schilbach K
Expert Opin Pharmacother
. 2025 Mar;
:1-14.
PMID: 40025677
Introduction: Acromegaly is a rare systemic disorder caused by an excess of growth hormone. Since surgical resection of the underlying tumor is not always successful, pharmacotherapy plays an invaluable role...
9.
Bonardi A, Supuran C
Expert Opin Pharmacother
. 2025 Feb;
PMID: 40021487
Introduction: Carbonic anhydrases (CAs) are enzymes involved in many physiologic and pathological processes connected with a diversity of conditions. Many of their inhibitors are used clinically for the management of...
10.
Lee K, Mohamed N, Abdul Aziz S, Mohamad Nazri D, Abdul Malek A, Lim J, et al.
Expert Opin Pharmacother
. 2025 Feb;
:1-10.
PMID: 40015692
Background: Major depressive disorder (MDD) is a growing global health concern, with its economic impact projected to reach USD 6.0 trillion by 2030. Treatment-resistant depression (TRD), characterized by non-responsiveness to...